Dr. Reddy's Laboratories Limited — Important, 29-04-2026: Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

Dr. Reddy's secured Health Canada approval for its generic Semaglutide Injection, becoming the first to get market authorization in Canada. This enables commercialization of this key diabetes treatment in the world's second-largest Semaglutide market, showcasing Dr. Reddy's complex generics expertise.